Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALKBH1 | Q13686 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 7/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 7/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | FPR1 | P21462 | 1/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | GRK6 | P43250 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | CPT1A | P50416 | 1/20 | 0.32 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30103142 | 1.00 | ALKBH1 (0.36) | ALKBH1GRIN1GRIN2BPTPN1FPR1 | |
| SCHEMBL24784634 | 0.92 | GRIN1 (0.34) | ALKBH1GRIN1GRIN2BFPR1FPR2 | |
| SCHEMBL30017932 | 0.92 | GRIN1 (0.34) | ALKBH1GRIN1GRIN2BFPR1FPR2 | |
| SCHEMBL30103033 | 0.91 | ALKBH1 (0.41) | ALKBH1GRIN1GRIN2BPTPN1DHODH | |
| SCHEMBL24785460 | 0.91 | ALKBH1 (0.41) | ALKBH1GRIN1GRIN2BPTPN1DHODH | |
| SCHEMBL24784619 | 0.87 | P2RX7 (0.38) | ALKBH1GRIN1GRIN2BPTPN1DHODH | |
| SCHEMBL30103035 | 0.87 | P2RX7 (0.38) | ALKBH1GRIN1GRIN2BPTPN1DHODH | |
| SCHEMBL24785112 | 0.85 | LDHA (0.36) | ALKBH1GRIN1GRIN2BPTPN1FPR1 | |
| SCHEMBL30018051 | 0.85 | LDHA (0.36) | ALKBH1GRIN1GRIN2BPTPN1FPR1 | |
| SCHEMBL24784631 | 0.84 | CNR2 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022257960-A1 | BICYCLIC COMPOUND FOR THE TREATMENT OF EP2 AND EP4 RECEPTOR-MEDIATED DISEASES | 武汉人福创新药物研发中心有限公司 | 2022-12-15 | — | — | WO | disclosed |